1,14-二甲基（3S，8S，9S，12S）-3,12-双（1,1-二甲基乙基）-8-羟基-4,11-二氧代-9-（苯甲基）-6-[[4- （2-吡啶基）苯基]甲基] -2,5,6,10,13-五叠氮丙二酸酯

产品名称：

198904-31-3
Atazanavir for system suitability
Atazanavir
BMS-232632
1,14-Dimethyl (3S,8S,9S,12S)-3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioate
阿扎那韦
1,14-二甲基（3S，8S，9S，12S）-3,12-双（1,1-二甲基乙基）-8-羟基-4,11-二氧代-9-（苯甲基）-6-[[4- （2-吡啶基）苯基]甲基] -2,5,6,10,13-五叠氮丙二酸酯

产品介绍：

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

阿扎那韦是一种抗病毒 HIV 蛋白酶抑制剂。

包装

Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式	C₃₈H₅₂N₆O₇
分子量	704.86
MDL编号	MFCD08435966

产品性质

等级	pharmaceutical primary standard
manufacturer/tradename	EDQM
格式	neat
储存温度	2-8℃
SMILES string	O=C(N[C@@H](C(C)(C)C)C(N[C@H]([C@H](CN(CC1=CC=C(C2=NC=CC=C2)C=C1)NC([C@@H](NC(OC)=O)C(C)(C)C)=O)O)CC3=CC=CC=C3)=O)OC
InChI	1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1
InChI key	AXRYRYVKAWYZBR-GASGPIRDSA-N

安全信息

象形图
警示用语：	Warning
危险声明	H319
预防措施声明	P264 - P280 - P305 + P351 + P338 - P337 + P313
危险分类	Eye Irrit. 2
储存分类代码	13 - Non Combustible Solids
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable